16 articles for thisTarget
              
              The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of the Binding Site of Chroman-4-one-Based Sirtuin 2-Selective Inhibitors using Photoaffinity Labeling in Combination with Tandem Mass Spectrometry.

University of Gothenburg
 
Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.

University of Gothenburg
 
Chroman-4-one and chromone based somatostatinß-turn mimetics.

University of Gothenburg
 
Synthesis and biological evaluation of second-generation tropanol-based androgen receptor modulators.

University of Gothenburg
 
Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells.

University of Gothenburg
 
Optimization of isochromanone based urotensin II receptor agonists.

University of Gothenburg
 
Novel and potent small-molecule urotensin II receptor agonists.

University of Gothenburg
 
Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.

University of Gothenburg
 
Preparation of 3-substituted-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET kinase inhibitors.

University of Gothenburg
 
Design, synthesis, and biological evaluation of chromone-based p38 MAP kinase inhibitors.

University of Gothenburg
 
Sulfone-based human liver pyruvate kinase inhibitors - Design, synthesis and in vitro bioactivity.

University of Gothenburg
 
Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators.

University of Gothenburg
 
Design and development of photoswitchable DFG-Out RET kinase inhibitors.

University of Gothenburg
 
Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase.

University of Gothenburg
 
Discovery and development of substituted thiadiazoles as inhibitors of Staphylococcus aureus Sortase A.

University of Gothenburg
 
Towards the development of chromone-based MEK1/2 modulators.

University of Gothenburg